Mrs Roseanne Peel
Senior Project Supervisor
Office of the PVC Health and Medicine (Public Health)
Ms Peel is a Registered Nurse and has completed a Graduate Certificate Intensive Care Nursing, qualified as an Authorised Nurse Immuniser, and has completed a Master of Public Health with Distiction (specialising in research methodology).
Ms Peel has a strong background in Intensive Care Nursing, Acute Stroke Nursing, Coronary Care Nursing and most recently qualified in Immunisation. Ms Peel has managed Case-Control Studies, Randomised Controlled Trials and Cohort Studies predominately with the School of Medicine and Public Health, University of Newcastle.
Roseanne has greater than ten years research project management experience and greater than thirty years nursing experience. Her current position involves the overall co-ordinating of a national multi-centre randomised controlled trial. She is also the longstanding Study Coordinator for the Hunter's Prospective Cohort Study - the Hunter Community Study, a Public Health and Health Services research resource that has attracted collaborations nationally and internationally and has produced over 60 publications including high impact journals such as Nature.Research Expertise
Research Research Assistant/Senior Research Assistant School of Medicine and Public Health, University of Newcastle, 2003-Present time Health Projects and Role: Study Manager Multi-Centre RCT: Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE) Trial (Pneumococcal Vaccine versus Placebo), Centre for Clinical Epidemiology and Biostatistics (CCEB), University of Newcastle October, 2014-Present Time Investigator, Pilot RCT: Does zinc supplementation delay or prevent diabetes in pre-diabetic adults? Centre for Clinical Epidemiology and Biostatistics (CCEB), University of Newcastle 2011-Present Time Research Study Co-ordinator: Olfactory Stress Test(Alzheimer’s Disease), CCEB, University of Newcastle, July 2012- Present time Research Study Co-ordinator & Clinic Manager Cohort Study Hunter Community Cohort Study, CCEB, University of Newcastle: January 2007 – Present Time Research Assistant: Extending Treatments and Networks in Depression (xTEND) Study CCEB, University of Newcastle: April 2010 – December 2011 Research Study Co-ordinator: Media Dr. And Heart Failure Validation Studies Clinical Pharmacology, University of Newcastle: June 2011 –December 2011 Study Co-ordinator RCT: Cerebral Hypothermia in Ischaemic Lesion (CHIL) Study Acute Stroke Service, Hunter New England Health: March 2009 – November 2010 Study Co-ordinator RCT: Comprehensive Stroke Unit Study CCEB, University of Newcastle: January 2009 – November 2010 Study Co-ordinator Case-Control Study – Acute Coronary Syndrome and Cox 2 Inhibitors/NSAIDS , Clinical Pharmacology: 2004-2006 Research Assistant : Case-Control Study – Heart Failure and Cox 2 Inhibitors/NSAIDS, Clinical Pharmacology: August –Dec 2003 Multicentre Open Label Randomised Controlled Trial – “Nice” Study (Normoglycaemia In intensive Care Evaluation), John Hunter Hospital ICU Multicentre Randomised Double Blinded Clinical Trial- “Safe” Study (Saline versus Albumin Fluid Evaluation), Multicentre Randomised Double Blinded Clinical Trial- “Selfotel” Study (Drug trial in head injured patients in Intensive Care), John Hunter Hospital ICU
Roseanne works with Professor John Attia and Dr Mark McEvoy and provides a supporting role in their research collaborations with students and academics within the University of Newcastle, other National Universities and International Universities.
- Master of Public Health, University of Newcastle
- Registered Nurse, NSW Nurses Registration Board
- Graduate Certificate in Nursing (Intens Care Nurs), John Hunter Hospital
- Health Protection
- Public Health
- Research role only
Fields of Research
|111799||Public Health and Health Services not elsewhere classified||100|
For publications that are currently unpublished or in-press, details are shown in italics.
Journal article (17 outputs)
|2015||Vashum KP, McEvoy MA, Hancock SJ, Islam MR, Peel R, Attia JR, Milton AH, 'Prevalence of and associations with excessive daytime sleepiness in an Australian older population.', Asia Pac J Public Health, 27 NP2275-NP2284 (2015)|
|2015||Chan JPL, Thalamuthu A, Oldmeadow C, Armstrong NJ, Holliday EG, McEvoy M, et al., 'Genetics of hand grip strength in mid to late life', Age, 37 1-10 (2015)|
Hand grip strength (GS) is a predictor of mortality in older adults and is moderately to highly heritable, but no genetic variants have been consistently identified. We aimed to identify single nucleotide polymorphisms (SNPs) associated with GS in middle-aged to older adults using a genome-wide association study (GWAS). GS was measured using handheld dynamometry in community-dwelling men and women aged 55Â¿85 from the Hunter Community Study (HCS, N = 2088) and the Sydney Memory and Ageing Study (Sydney MAS, N = 541). Genotyping was undertaken using Affymetrix microarrays with imputation to HapMap2. Analyses were performed using linear regression. No genome-wide significant results were observed in HCS nor were any of the top signals replicated in Sydney MAS. Gene-based analyses in HCS identified two significant genes (ZNF295, C2CD2), but these results were not replicated in Sydney MAS. One out of eight SNPs previously associated with GS, rs550942, located near the CNTF gene, was significantly associated with GS (p = 0.005) in the HCS cohort only. Study differences may explain the lack of consistent results between the studies, including the smaller sample size of the Sydney MAS cohort. Our modest sample size also had limited power to identify variants of small effect. Our results suggest that similar to various other complex traits, many genetic variants of small effect size may influence GS. Future GWAS using larger samples and consistent measures may prove more fruitful at identifying genetic contributors for GS in middle-aged to older adults.
|2014||Holliday EG, Attia J, Hancock S, Koloski N, McEvoy M, Peel R, et al., 'Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome', American Journal of Gastroenterology, 109 770-772 (2014) [C1]|
|2014||Moayyeri A, Hsu Y-H, Karasik D, Estrada K, Xiao S-M, Nielson C, et al., 'Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium', HUMAN MOLECULAR GENETICS, 23 3054-3068 (2014) [C1]|
|2014||Handley TE, Hiles SA, Inder KJ, Kay-Lambkin FJ, Kelly BJ, Lewin TJ, et al., 'Predictors of Suicidal Ideation in Older People: A Decision Tree Analysis', AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 22 1325-1335 (2014) [C1]|
|2014||Islam MR, Attia J, Alauddin M, McEvoy M, McElduff P, Slater C, et al., 'Availability of arsenic in human milk in women and its correlation with arsenic in urine of breastfed children living in arsenic contaminated areas in Bangladesh.', Environmental Health: A Global Access Science Source, 13 1-10 (2014) [C1]|
|2014||McEvoy M, Schofield P, Smith W, Agho K, Mangoni AA, Soiza RL, et al., 'Memory Impairment is Associated with Serum Methylarginines in Older Adults', CURRENT ALZHEIMER RESEARCH, 11 97-106 (2014) [C1]|
|2014||Napthali K, Boyle M, Tran H, Schofield PW, Peel R, McEvoy M, et al., 'Thyroid antibodies, autoimmunity and cognitive decline: is there a population-based link?', Dement Geriatr Cogn Dis Extra, 4 140-146 (2014) [C1]|
|2013||McEvoy MA, Schofield P, Smith W, Agho K, Mangoni AA, Soiza RL, et al., 'Serum methylarginines and incident depression in a cohort of older adults', Journal of Affective Disorders, 151 493-499 (2013) [C1]|
|2013||Islam MR, Arslan I, Attia J, McEvoy M, McElduff P, Basher A, et al., 'Is Serum Zinc Level Associated with Prediabetes and Diabetes?: A Cross-Sectional Study from Bangladesh', PLOS ONE, 8 (2013) [C1]|
|2013||McEvoy MA, Schofield PW, Smith WT, Agho K, Mangoni AA, Soiza RL, et al., 'Serum Methylarginines and Spirometry-Measured Lung Function in Older Adults', PLOS ONE, 8 (2013) [C1]|
|2012||Suthers B, Hansbro PM, Thambar S, McEvoy MA, Peel R, Attia JR, 'Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease', Vaccine, 30 3983-3985 (2012) [C1]|
|2012||Holliday EG, Maguire JM, Evans T-J, Koblar SA, Jannes J, Sturm J, et al., 'Common variants at 6p21.1 are associated with large artery atherosclerotic stroke', Nature Genetics, 44 1147-1153 (2012) [C1]|
|2012||Islam MR, Khan I, Hassan SMN, McEvoy MA, D'Este CA, Attia JR, et al., 'Association between type 2 diabetes and chronic arsenic exposure in drinking water: A cross sectional study in Bangladesh', Environmental Health, 11 1-8 (2012) [C1]|
|2011||McGettigan P, Lincz L, Attia JR, McElduff P, Bissett L, Peel R, et al., 'The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene', British Journal of Clinical Pharmacology, 72 707-714 (2011) [C1]|
|2010||McEvoy MA, Smith WT, D'Este CA, Duke JM, Peel R, Schofield PW, et al., 'Cohort Profile: The Hunter Community Study', International Journal of Epidemiology, 39 1452-1463 (2010) [C1]|
|Show 14 more journal articles|
Conference (4 outputs)
|2011||Khan I, Hassan S, McEvoy MA, D'Este CA, Attia JR, Peel R, Hasnat MA, 'Association between type 2 diabetes and chronic arsenic exposure in Bangladesh', Epidemiology, - (2011) [E3]|
|2009||McGettigan P, Peel R, Stokes BJ, Henderson KM, Whitaker DE, Henry D, 'What did 'safe' mean to prescribers of selective COX-2 inhibitors?', Basic & Clinical Pharmacology & Toxicology, Edinburgh, UK (2009) [E3]|
|2009||Henry D, Lincz L, Attia JR, McElduff P, Bisset L, Peel R, et al., 'Polymorphisms in two regions of the cyclo-oxygenase-2 gene associated with variation in risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors', Basic & Clinical Pharmacology & Toxicology, Edinburgh, UK (2009) [E3]|
|Show 1 more conference|